BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25978658)

  • 1. Toxic erythema of chemotherapy following leukemia cutis.
    Kaskas N; DiGiorgio C; Vincent B; Walia S; Mermilliod J
    J La State Med Soc; 2014; 166(6):236-8. PubMed ID: 25978658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-SCT for AML in second remission: CALGB study 9620.
    Linker CA; Owzar K; Powell B; Hurd D; Damon LE; Archer LE; Larson RA;
    Bone Marrow Transplant; 2009 Sep; 44(6):353-9. PubMed ID: 19289999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases.
    Demirçay Z; Gürbüz O; Alpdoğan TB; Yücelten D; Alpdoğan O; Kurtkaya O; Bayik M
    Int J Dermatol; 1997 Aug; 36(8):593-8. PubMed ID: 9329890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report.
    Hsu HC; Chiu CF; Tan TD; Chau WK; Tseng CS; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):305-11. PubMed ID: 8605644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resident rounds. Part III: Neutrophilic eccrine hidradenitis in the setting of acute myelogenous leukemia treated with cytarabine.
    Shlapak D; Kerisit K; Lin C; Wang A; Stumpf B
    J Drugs Dermatol; 2013 Feb; 12(2):231-2. PubMed ID: 23550319
    [No Abstract]   [Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
    Battipaglia G; Avilia S; Morelli E; Caranci F; Perna F; Camera A
    Ann Hematol; 2012 Aug; 91(8):1327-8. PubMed ID: 22237936
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening conjunctival presentation of myeloid sarcoma.
    Alexander C; Lee GA; Whitehead K; Bashford J; Jefferies PD
    Clin Exp Ophthalmol; 2008 Nov; 36(8):775-7. PubMed ID: 19128384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON).
    Daenen S; Löwenberg B; Sonneveld P; van Putten WL; Verhoef G; Verdonck LF; van Veldhoven M; Huijgens PC
    Leukemia; 1994 Jan; 8(1):6-10. PubMed ID: 8289499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophilic eccrine hidradenitis induced by cytarabine.
    Grahovac M; Maximiliane Ehmann L; Flaig M; Reibke R; Wollenberg A
    Acta Dermatovenerol Croat; 2012; 20(4):272-5. PubMed ID: 23317491
    [No Abstract]   [Full Text] [Related]  

  • 12. The combination of fludarabine, cytarabine and etoposide is an active and well-tolerated regimen in relapsed/refractory acute myeloid leukemia.
    Aldoss I; Ji L; Haider M; Pullarkat V
    Acta Haematol; 2014; 131(4):202-7. PubMed ID: 24296475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
    Taverna C; Jacky E; Sauter C
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
    [No Abstract]   [Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
    Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
    Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
    Lee SS; Lee JH; Lee JH; Kim DY; Kim SH; Lim SN; Lee YS; Seol M; Ryu SG; Kang YA; Jang S; Park CJ; Chi HS; Yun SC; Lee KH
    Leuk Res; 2009 Apr; 33(4):511-7. PubMed ID: 18819710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia.
    Paciucci PA; Dutcher JP; Cuttner J; Strauman JJ; Wiernik PH; Holland JF
    Leukemia; 1987 Jul; 1(7):565-7. PubMed ID: 3478540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).
    Amadori S; Suciu S; Stasi R; Salih HR; Selleslag D; Muus P; De Fabritiis P; Venditti A; Ho AD; Lübbert M; Thomas X; Latagliata R; Halkes CJ; Falzetti F; Magro D; Guimaraes JE; Berneman Z; Specchia G; Karrasch M; Fazi P; Vignetti M; Willemze R; de Witte T; Marie JP
    J Clin Oncol; 2013 Dec; 31(35):4424-30. PubMed ID: 24127442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siblings presenting with progressive congenital aleukemic leukemia cutis.
    Agrawal AK; Guo H; Golden C
    Pediatr Blood Cancer; 2011 Aug; 57(2):338-40. PubMed ID: 21425444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
    Erikci AA; Ozturk A; Tekgunduz E; Sayan O
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.